Tirzepatide injections
A once-weekly injectable that targets two gut hormones — GIP and GLP-1 — to help regulate appetite and blood sugar, prescribed as part of a medically supervised weight-management program.
Get startedPrescription only. Subject to provider evaluation and approval. Not everyone is a candidate.
Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist. By acting on the receptors for these two naturally occurring gut hormones, it can help slow gastric emptying, reduce appetite, and support blood-sugar regulation. When prescribed by your provider, it is used to support weight management together with reduced-calorie eating and increased physical activity.
How it works with AVArx
- Complete a free online medical questionnaire about your goals, history, and current medications.
- A U.S.-licensed provider reviews your information and determines whether tirzepatide is appropriate for you.
- If prescribed, your medication is dispensed by a licensed pharmacy and shipped to your door, typically with a dosing and titration schedule set by your provider.
- Your care team is available to adjust your dose, manage refills, and answer questions.
Before a prescription is issued, AVArx arranges any synchronous (real-time) visit required by the state where you receive care. States requiring synchronous (real-time) audio/phone calls: Arkansas, District of Columbia, Idaho, Mississippi, and Virginia (not telephone/cellular). States requiring synchronous (real-time) video calls: Kansas, New Mexico, New York, South Dakota, Vermont, and Wisconsin (audio-synchronous accepted for Medicaid patients).
Important Safety Information
Boxed Warning: Risk of Thyroid C-Cell Tumors
In studies in rodents, tirzepatide caused thyroid C-cell tumors. It is not known whether tirzepatide causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use tirzepatide if you or any of your family members have a history of MTC or have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use if you
- have a personal or family history of MTC or MEN 2;
- have had a serious allergic reaction to tirzepatide or any of its ingredients.
Talk to your provider before use if you
have or have had problems with your pancreas (pancreatitis) or gallbladder, kidney problems, diabetic retinopathy, or are pregnant, breastfeeding, or planning to become pregnant.
Possible serious side effects
Inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially if used with insulin or a sulfonylurea), kidney injury (often related to dehydration from nausea, vomiting, or diarrhea), serious allergic reactions, and changes in vision. Seek medical attention for severe or persistent symptoms.
Common side effects
Nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion.
This is not a complete list of side effects. Tell your provider about all the medicines you take. Talk to your provider and review the full prescribing information for complete safety information. To report a side effect, contact your provider or email info@getavarx.com.
For broader context on GLP-1 care, eligibility, and process, see the GLP-1 treatment guide and online GLP-1 weight loss care overview. You may also review semaglutide if your provider is considering an alternative option.